Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America-Reference-Cited by-同舟云学术

Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America

Published:2010-12 Issue: Volume: Page:19
ISSN:1176-6328
Container-title:Neuropsychiatric Disease and Treatment
language:en
Short-container-title:NDT

Author:

Apiquian Rogelio,Cordoba Rodrigo,Louza M R

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability

;Neuropsychiatric Disease and Treatment;2020-09

2. Paliperidone palmitate once-monthly maintains improvement in functioning domains of the Personal and Social Performance scale compared with placebo in subjects with schizoaffective disorder;Schizophrenia Research;2018-02

3. Enhancing adherence, subjective well-being and quality of life in patients with schizophrenia: which role for long-acting risperidone?;Therapeutic Advances in Psychopharmacology;2015-08-12

4. Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics;American Journal of Health-System Pharmacy;2015-03-01

5. Cost-effectiveness analysis of paliperidone palmitate versus long-acting risperidone as maintenance treatment in schizophrenia patients in Italy;Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish;2014-12-18